Insulet Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
2025/07/18

DJ Insulet Corp. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Insulet Corp. (PODD) shed 1.67% to $283.45 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.54% to 6,297.36 and the Dow Jones Industrial Average rising 0.52% to 44,484.49.

This was the stock's third consecutive day of losses.

Insulet Corp. closed 13.93% below its 52-week high of $329.33, which the company achieved on May 21st.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Eli Lilly & Co. (LLY) fell 3.58% to $761.50, DexCom Inc. (DXCM) fell 0.04% to $84.10, and Johnson & Johnson $(JNJ)$ fell 1.09% to $162.98.

Trading volume (581,947) remained 275,182 below its 50-day average volume of 857,129.

Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

July 17, 2025 17:08 ET (21:08 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10